北美代谢组学服务市场预测至 2028 年 - 按服务类型(靶向代谢组学服务和非目标代谢组学服务)和应用(制药和生物技术行业、农业技术和环境)划分的 COVID-19 影响和区域分析

TIPRE00026149 | Pages: 102 | Biotechnology | Dec 2021 | Type: Regional | Status: Published

市场介绍

北美代谢组学服务市场已细分为美国、加拿大和墨西哥。 2021年,美国在北美代谢组学服务市场中占据最大份额。技术进步的日益采用和研发活动的增加预计将加速代谢组学服务市场的增长。此外,大型医疗保健企业的存在和代谢组学服务的不断增长正在推动该地区市场的扩张。在北美,美国占有代谢组学服务市场的重要份额。该国市场的增长主要是由癌症等慢性病患病率的增加推动的。例如,根据美国国家癌症研究所的数据,2020 年该国将出现 1,735,350 例新癌症病例。乳腺癌、肺癌和支气管癌、前列腺癌、结肠癌和直肠癌、黑色素瘤和肝癌是最常见的癌症类型。癌症。该国癌症发病率正以惊人的速度增加,导致对癌症诊断的需求增加。此外,用于制药公司以及学术和研究机构开发各种药物、不断增长的老年人口、传染病和其他治疗方法的投资和资金不断增加是主要驱动因素之一。癌症发病率上升是推动北美代谢组学服务市场增长的主要因素。

在北美,美国等国家报告的新冠肺炎病例数最高19 例。疫情导致医疗卫生领域混乱,医院对诊断和治疗设备的需求过度增加。例如,北美国家对呼吸机、呼吸器和体外诊断 (IVD) 测试的需求急剧上升。对个人防护套件的需求也显着增加。 FDA 加大了支持人们健康的力度,并为医院和医疗保健公司推出了几项指南。公司还加强了诊断测试和治疗设备的研发活动。例如,Thermo Fisher Scientific、F. Hoffmann-La Roche AG、EverlyWell 和 Abbott 等公司处于 COVID-19 诊断试剂盒生产的前沿。 Thermo Fisher Scientific 已将产量提高到 4 月份每周可生产 500 万份检测试剂。同样,雅培还获得了即时测试的紧急使用授权 (EUA),该测试可以在几分钟内提供结果。

市场概览和动态

北美代谢组学服务市场预计将从2021年的1.7889亿美元增长到2028年的6.8585亿美元;预计 2021 年至 2028 年复合年增长率为 21.2%。该地区的经济体正在为主要市场参与者扩大业务创造重大机会。大多数参与者集中在大国,因为这些国家患有慢性病的人口众多。随着生产成本不断上升,医疗保健公司正在努力产生足够的收入来招待投资者。一些增长中经济体的市场预计将成为主要参与者扩展其行业提供更可靠和更有利可图的增长机会的重要组成部分。生物技术的进步增加了医疗保健市场对诊断的需求,鼓励引入更多分析系统并促进向个性化医疗的转变。新兴国家在传染病检测、分子肿瘤学和药物基因组学方面存在新的机遇。因此,医疗保健公司可以针对多个国家的患者或消费者。该行业的各个参与者一直将大量收入投入到研发活动中,以开发更好、更先进的产品和技术,用于医疗保健行业。因此,癌症等疾病数量的增加以及一些国家的进步可能会提振市场,并预计在预测期内为市场参与者提供显着的增长机会。

< p>主要市场细分

北美代谢组学服务市场已根据服务类型进行细分,应用程序和国家。根据服务类型,北美代谢组学服务市场分为靶向代谢组学服务和非靶向代谢组学服务。目标代谢组学服务领域在 2020 年占据市场主导地位,预计将在预测期内增长最快。根据应用,市场分为制药和生物技术行业、农业技术和环境。制药和生物技术行业在 2020 年占据市场主导地位,预计将在预测期内增长最快。同样,制药和生物技术行业细分为生物标志物发现、药物发现、毒理学测试等。

主要来源和上市公司

u>

准备本北美代谢组学服务市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有巴斯夫股份公司(BASF SE);华大基因; Biocrates 生命科学股份公司;切诺姆斯公司;创意蛋白质组学;弗雷德·哈钦森癌症研究中心;代谢龙公司;分子的你; RTI 国际; TMIC;和西海岸代谢组学中心等

购买报告的理由

  • 了解北美代谢组学服务市场格局并确定最有可能保证强劲的细分市场返回
  • 了解北美代谢组学服务市场不断变化的竞争格局,保持领先地位
  • 有效规划通过确定最有可能销售前景的细分市场,在北美代谢组学服务市场进行并购和合作交易
  • 通过对市场表现的敏锐和全面分析,帮助做出明智的业务决策北美代谢组学服务市场各个细分市场
  • 获取北美地区2021-2028年各个细分市场的市场收入预测 span>

北美代谢组学服务市场细分

北美代谢组学服务市场 - 按服务类型

  • 靶向代谢组学服务
  • 非靶向代谢组学服务

North美国代谢组学服务市场 - 按应用

  • 制药和生物技术行业
    • 生物标志物发现
    • 药物发现
    • 毒理学测试
    • 其他
  • 农业科技
  • 环境
< p>北美代谢组学服务市场 - 按国家/地区

  • 美国
  • 加拿大
  • 墨西哥

北部美国代谢组学服务市场 -公司简介

  • BASF SE
  • 华大基因
  • biocrates life sciences ag
  • Chenomx Inc.
  • Chenomx Inc.
  • 创意蛋白质组学
  • 弗雷德·哈钦森癌症研究中心
  • Metabolon, Inc .
  • 分子你
  • RTI国际
  • TMIC span>
  • 西海岸代谢组学中心

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Metabolomics Services Market – By Service Type

1.3.2        North America Metabolomics Services Market – By Application

1.3.3        North America Metabolomics Services Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Metabolomics Services Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Metabolomics Services Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidences of Cancer

5.1.2        Surge in Adoption of Metabolomics and Investments by Market Players

5.2         Market Restraints

5.2.1        High Price of Tools, Instruments, and Usage

5.3         Market Opportunities

5.3.1        Development Opportunities in Several Countries

5.4         Future Trends

5.4.1        Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy

5.5         Impact Analysis

6.           Metabolomics Services Market– North America Analysis

6.1         North America Metabolomics Services Market Revenue Forecast and Analysis

7.           North America Metabolomics Services Market Revenue and Forecasts to 2028– by Service Type

7.1         Overview

7.2         North America Metabolomics Services Market, By Service Type 2021 & 2028 (%)

7.3         Targeted Metabolomics Service

7.3.1        Overview

7.3.2        Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Untargeted Metabolomics Service

7.4.1        Overview

7.4.2        Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)

8.           North America Metabolomics Services Market Revenue and Forecasts to 2028 – by Application

8.1         Overview

8.2         North America Metabolomics Services Market Share by Application 2021 & 2028 (%)

8.3         Pharmaceutical and Biotechnology Industry

8.3.1        Overview

8.3.2        Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)

8.3.2.1          Biomarker Discovery

8.3.2.1.1          Overview

8.3.2.1.2          Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)

8.3.2.2          Toxicological Testing

8.3.2.2.1          Overview

8.3.2.2.2          Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)

8.3.2.3          Drug Discovery

8.3.2.3.1          Overview

8.3.2.3.2          Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)

8.3.2.4          Others

8.3.2.4.1          Overview

8.3.2.4.2          Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Agritech

8.4.1        Overview

8.4.2        Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Environment

8.5.1        Overview

8.5.2        Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)

9.           North America Metabolomics Services Market Revenue and Forecasts to 2028 – Country Analysis

9.1         Overview

9.1.1        North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)

9.1.1.1          US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1          US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.2          US: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)

9.1.1.1.3          US: Metabolomics Services Market, by Application, 2019–2028 (USD Million)

9.1.1.1.3.1       US: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)

9.1.1.2          Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.1          Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.2          Canada: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)

9.1.1.2.3          Canada: Metabolomics Services Market, by Application, 2019–2028 (USD Million)

9.1.1.2.3.1       Canada: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)

9.1.1.3          Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1          Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.2          Mexico: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)

9.1.1.3.3          Mexico: Metabolomics Services Market, by Application, 2019–2028 (USD Million)

9.1.1.3.3.1       Mexico: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on North America Metabolomics Services Market

10.1      Overview

11.        North America Metabolomics Services Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      BASF SE

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      TMIC

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Creative Proteomics

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BGI

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      RTI International

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Fred Hutchinson Cancer Research Center

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      West Coast Metabolomics Center

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Molecular You

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Metabolon, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   biocrates life sciences ag

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

12.11   Chenomx Inc.

12.11.1  Key Facts

12.11.2  Business Description

12.11.3  Products and Services

12.11.4  Financial Overview

12.11.5  SWOT Analysis

12.11.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             North America Metabolomics Services Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)

Table 8.             Mexico Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             Mexico Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)

Table 11.          organic Developments Done By Companies

Table 12.          Inorganic Developments Done By Companies

Table 13.          Glossary of Terms, North America Metabolomics Services Market

 


LIST OF FIGURES

Figure 1.           North America Metabolomics Services Market Segmentation

Figure 2.           North America Metabolomics Services Market, By Country

Figure 3.           North America Metabolomics Services Market Overview

Figure 4.           Targeted Metabolomics Service Segment Held Largest Share of Type Segment in North America Metabolomics Services Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to North America Metabolomics Services Market

Figure 9.           North America Metabolomics Services Market– By Revenue Forecast and Analysis – 2019- 2028

Figure 10.        North America Metabolomics Services Market, by Service Type 2021 & 2028 (%)

Figure 11.        North America Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        North America Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        North America Metabolomics Services Market Share by Application 2021 & 2028 (%)

Figure 14.        North America Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 15.        North America Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 16.        North America Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 17.        North America Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 18.        North America Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        North America Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        North America Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        North America: Metabolomics Services Market, by Key Country – Revenue (2021) (USD Million)

Figure 22.        North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)

Figure 23.        US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic in North American Country Markets

 

  1. BASF SE
  2. BGI
  3. biocrates life sciences ag
  4. Chenomx Inc.
  5. Creative Proteomics
  6. Fred Hutchinson Cancer Research Center
  7. Metabolon, Inc.
  8. Molecular You
  9. RTI International
  10. TMIC
  11. West Coast Metabolomics Center
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Metabolomics Services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America Metabolomics Services market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Metabolomics Services market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000